Accelerate Diagnostics, Inc. - Common Stock, par value $0.001 per share (AXDX)

Historical Holders from Q1 2014 to Q3 2025

Symbol
AXDX on Nasdaq
Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
27,795,576
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
0
Holdings value
$0
Number of holders
0
Number of sells
-1
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Accelerate Diagnostics, Inc. - Common Stock, par value $0.001 per share (AXDX)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Indaba Capital Management, L.P. 9.9% $2,146,374 2,751,762 Indaba Capital Management, L.P. 04 Feb 2025

Institutional Holders of Accelerate Diagnostics, Inc. - Common Stock, par value $0.001 per share (AXDX)

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 0 $0 -$2,082 0
2025 Q2 325,239 $2,082 $0.006400 1
2025 Q1 325,239 $227,992 $0.7010 1
2024 Q4 325,239 $390,287 $1.20 1
2024 Q3 325,239 $556,158 $1.71 1
2024 Q2 325,239 $380,529 $1.17 1
2024 Q1 325,239 $321,986 -$171,462 $0.9900 1
2023 Q4 294,235 $1,153,398 -$24,627 $3.92 2
2023 Q3 292,312 $1,680,790 -$27,282,525 $5.75 2
2023 Q2 22,061,032 $17,867,197 -$1,702,997 $0.8100 48
2023 Q1 24,494,123 $17,145,621 -$735,427 $0.7000 64
2022 Q4 25,486,950 $17,986,481 -$2,305,148 $0.7060 70
2022 Q3 27,079,683 $41,163,383 +$12,970,280 $1.52 74
2022 Q2 18,728,083 $18,593,968 -$4,851,056 $0.9928 65
2022 Q1 22,669,371 $32,633,607 -$3,084,441 $1.44 92
2021 Q4 23,891,706 $124,684,979 +$1,055,814 $5.22 101
2021 Q3 23,099,769 $134,695,831 -$6,513,003 $5.83 101
2021 Q2 24,159,157 $194,678,639 -$4,130,397 $8.06 91
2021 Q1 24,650,481 $205,050,300 -$24,726,773 $8.32 97
2020 Q4 27,849,074 $211,099,010 -$14,688,721 $7.58 111
2020 Q3 29,199,735 $311,275,609 -$5,072,944 $10.66 111
2020 Q2 29,541,154 $447,807,639 +$4,134,661 $15.16 119
2020 Q1 29,498,547 $245,721,615 -$8,837,710 $8.33 104
2019 Q4 30,328,876 $512,536,422 +$10,446,657 $16.90 104
2019 Q3 29,694,415 $551,449,031 -$3,167,985 $18.57 111
2019 Q2 29,653,843 $678,519,754 +$50,943,804 $22.88 115
2019 Q1 27,547,939 $579,096,482 +$584,489 $21.02 112
2018 Q4 27,669,101 $318,242,603 +$10,087,379 $11.50 104
2018 Q3 26,682,530 $612,216,265 +$44,740,464 $22.95 116
2018 Q2 24,727,140 $551,407,882 +$80,296,470 $22.30 115
2018 Q1 21,162,719 $483,558,760 +$380,278 $22.85 115
2017 Q4 20,749,473 $543,694,478 -$29,711,588 $26.20 113
2017 Q3 22,229,470 $498,975,777 +$42,806,085 $22.45 116
2017 Q2 20,246,463 $553,716,021 +$12,686,479 $27.35 116
2017 Q1 20,321,003 $492,502,628 +$161,301,638 $24.20 96
2016 Q4 15,285,979 $317,214,271 +$15,860,697 $20.75 106
2016 Q3 14,419,465 $393,068,474 +$29,283,887 $27.26 99
2016 Q2 13,556,644 $195,816,651 -$4,160,693 $14.39 93
2016 Q1 13,815,278 $198,241,827 -$7,748,331 $14.37 90
2015 Q4 13,637,689 $291,760,310 +$71,008,209 $21.49 94
2015 Q3 10,400,675 $168,280,869 +$102,147 $16.18 86
2015 Q2 10,060,681 $259,658,742 +$36,056,201 $25.81 84
2015 Q1 8,673,016 $195,117,181 +$18,570,610 $22.50 72
2014 Q4 7,902,846 $151,750,645 +$12,272,876 $19.19 76
2014 Q3 5,376,536 $115,477,901 +$11,529,039 $21.48 69
2014 Q2 4,795,298 $124,673,140 -$83,316,354 $26.00 73
2014 Q1 8,874,805 $193,414,456 +$112,583,835 $21.81 55